Nikhil Prasad Fact checked by:Thailand Medical News Team Aug 17, 2026 59 minutes ago
Scientists are exploring new ways to strengthen the cancer-fighting potential of ferulic acid, a natural plant compound found in cereal grains, fruits and vegetables. A new scientific review suggests that advanced drug-delivery systems and specially designed chemical derivatives could overcome major problems that have prevented the compound from progressing toward clinical cancer treatment.
New research highlights how nanotechnology and chemical modifications could strengthen the cancer-fighting
potential of ferulic acid.
Ferulic acid is particularly abundant in the bran of wheat, rice, oats and corn. Researchers have become interested in the compound because laboratory studies suggest it can interfere with several processes that cancer cells depend upon for growth, survival and spread.
Researchers Examine Ferulic Acid Against Cancer
The review was conducted by Tiziana Fiore, Michela Giuliano, Claudia Pellerito and Sonia Emanuele from the Department of Physics and Chemistry “Emilio Segrè,” University of Palermo; Department of Biological, Chemical and Pharmaceutical Sciences and Technologies (STEBICEF), University of Palermo; and Department of Biomedicine, Neurosciences and Advanced Diagnostics (BIND), University of Palermo, Italy.
Evidence examined by the researchers indicates that ferulic acid can slow uncontrolled cancer-cell multiplication by interfering with the cell cycle and important survival pathways including PI3K/Akt, MAPK and NF-κB.
It can also encourage cancer cells to undergo programmed death. Studies involving colon, breast, liver and lung cancer models have linked ferulic acid to apoptosis, autophagy and ferroptosis—different biological mechanisms through which damaged or abnormal cells can be destroyed.
Ferulic Acid Could Also Interfere with Cancer Spread
Importantly, this Thailand
Medical News report highlights evidence that ferulic acid could reduce cancer-cell migration and invasion. It can suppress MMP-2 and MMP-9, enzymes that help tumor cells break down surrounding tissue and spread.
Ferulic acid also appears capable of influencing epithelial-mesenchymal transition, a process that can make cancer cells more mobile and invasive. Researchers additionally described its unusual ability to behave mainly as an antioxidant under normal conditions while potentially acting as a pro-oxidant within certain cancer cells, increasing oxidative stress enough to help trigger their death.
Nanotechnology Could Make Ferulic Acid More Powerful
The major problem is delivery. Ferulic acid has poor water solubility, relatively low absorption, rapid metabolism and limited bioavailability, greatly restricting its potential clinical usefulness.
Researchers are therefore experimenting with nanoparticles, liposomes, nanocapsules, micelles and nanotubes. In one study reviewed, placing ferulic acid inside cyclodextrin nanosponges improved its solubility by as much as 15-fold and increased its cancer-cell-killing effects in breast cancer cells.
/>
Other experiments have combined ferulic acid with chemotherapy drugs. PEGylated liposomes carrying both ferulic acid and doxorubicin produced greater toxicity against cancer cells while showing no effect on normal cells in that particular laboratory study.
Chemical Derivatives Produce Intriguing Results
Another strategy involves chemically modifying ferulic acid or attaching it to other compounds. One derivative, tributyltin(IV) ferulate, or TBT-F, significantly reduced the viability of HCT116, Caco-2 and HT-29 colon cancer cells at nanomolar concentrations. Under the same experimental conditions, ordinary ferulic acid was ineffective. Researchers linked TBT-F's activity to oxidative stress, endoplasmic reticulum stress and autophagic cell death.
Conclusions
Ferulic acid and its engineered derivatives offer intriguing possibilities, particularly when combined with nanotechnology and other anticancer agents. However, these findings remain largely preclinical. More animal research, detailed toxicity assessments and eventually controlled human studies will be essential before any ferulic acid-based strategy can be considered a proven cancer therapy.
The study findings were published in the peer reviewed International Journal of Molecular Sciences.
https://www.mdpi.com/1422-0067/27/16/7324
Read Also:
https://www.thailandmedical.news/articles/cancer
https://www.thailandmedical.news/articles/herbs-and-phytochemicals
Share
Tweet
Share
